IPO GMP Explained: What It Means and Should You Trust It?

If you follow IPOs in India, you have almost certainly seen the term GMP — Grey Market Premium. It appears in WhatsApp forwards, finance YouTube channels, and IPO tracking websites like TopFund. But what exactly is GMP? How is it calculated? And most importantly — should you make investment decisions based on it?

What is GMP (Grey Market Premium)?

GMP stands for Grey Market Premium. It is the price at which IPO shares are bought and sold in an unofficial, unregulated market before the IPO officially lists on NSE or BSE.

The "grey market" is not illegal — it operates in a grey zone between legal and illegal. Transactions happen through personal trust networks, not through any regulated exchange. No paperwork, no KYC, no SEBI oversight.

GMP represents the premium over the IPO issue price that buyers are willing to pay in this unofficial market. For example:

• IPO issue price: ₹150
• GMP: ₹40
• Expected listing price implied by GMP: ₹150 + ₹40 = ₹190
• GMP percentage: 40/150 × 100 = 26.67%

How is GMP Determined?

GMP is determined purely by supply and demand in the grey market. Factors that influence GMP include:

• Subscription levels — A heavily oversubscribed IPO (50x, 100x) signals strong demand, pushing GMP higher
• Market sentiment — Bull markets see higher GMPs across the board
• Company fundamentals — Strong revenue growth, low debt, and clear business model drive higher GMP
• Competitor valuations — If listed peers trade at high multiples, grey market bidders price in similar premiums
• Anchor investor quality — If marquee institutional investors like FIIs or big mutual funds participate, GMP rises

GMP vs Kostak Rate vs Subject to Sauda

Three terms are often confused:

• GMP — Premium per share over issue price. The main number everyone tracks.
• Kostak Rate — The price at which someone buys your entire IPO application before allotment. If Kostak is ₹500, you sell your full application for ₹500 regardless of allotment outcome.
• Subject to Sauda — A conditional deal where you sell your application only if you get allotment. Price is higher than Kostak but conditional.

Is GMP Reliable for Predicting Listing Gains?

This is the most important question. The honest answer: GMP is directionally useful but not precisely reliable.

Historical data shows that IPOs with GMP above 30% do tend to list with gains — but the actual listing price rarely matches GMP exactly. Factors that create divergence:

• Manipulators — Large operators can artificially inflate GMP to create FOMO and drive retail application volume, then exit quickly after listing
• Market crashes — A sudden market selloff between subscription close and listing can wipe out GMP-implied gains entirely
• Lock-up selling — Anchor investors can sell after a 30-day lock-up, creating post-listing selling pressure
• Operator exits — Grey market operators who drove up GMP dump shares at listing, crashing the price

Real examples of GMP vs actual listing:

• IPO with GMP +40% → Listed +65% (GMP underestimated)
• IPO with GMP +35% → Listed +12% (GMP overestimated)
• IPO with GMP +25% → Listed -8% (GMP completely wrong)

When Should You Pay Attention to GMP?

GMP is most useful as a sentiment indicator, not a price prediction tool. Pay attention when:

• GMP is very high (above 40%) AND subscription is 30x+ — strong dual signal of genuine demand
• GMP is negative — a strong warning signal that the market expects the IPO to list below issue price
• GMP is rising consistently from open to close — increasing demand is a positive signal

Be cautious when:

• GMP spikes suddenly without a corresponding spike in subscription numbers — possible manipulation
• GMP is high but the company's fundamentals are weak — operator-driven inflation
• You are reading GMP from a single source — cross-check multiple sources

How TopFund Shows GMP

TopFund updates GMP data every 15 minutes, sourcing from multiple grey market channels. We show:

• Current GMP in ₹
• GMP as a percentage of issue price
• Expected listing price (issue price + GMP)
• Subscription data alongside GMP for context

All GMP data on TopFund comes with a clear disclaimer: GMP is unofficial and indicative only. It does not guarantee actual listing performance.

The Bottom Line

GMP is a useful tool in your IPO research toolkit — not the only tool. Use it alongside company fundamentals, subscription data, sector outlook, and valuation multiples. Never apply to an IPO solely because the GMP is high. And never skip an IPO solely because the GMP is low.

Track live GMP for all active IPOs on TopFund's IPO tracker — free, updated every 15 minutes, no login required.